Janssen Pharmaceutica — Clinical Trial Site

15 Registered trials

1 Currently recruiting

Organisation

Janssen Pharmaceutica

Location

Antwerp, Belgium

Identifier

ORG-100000625

Address

Lange Bremstraat 70, 2170, Belgium

Departments

Clinical Pharmacology Unit
ClinPharm Unit Merks
ClinPharm Unit Merksem
Janssen Clinical Pharmacology Unit

Clinical trials at this site (15)

Search interface

A study to compare the amount of milvexian in blood when given as pediatric and adult tablet formulations, to assess the effect of food inta… Recruiting

2023-508515-23-00 atherothrombotic and thromboembolic disorders 3 2024-03-19
A three-part trial in healthy volunteers to find out how long icotrokinra stays in and acts on the body when administered as different table… Ended

2025-521005-41-00 Inflammatory Conditions 3 2025-06-30
A Phase 1, Open-label, Randomized, Crossover Study to Assess the Effect of Different Types of Co-administered Oral Liquids on the Relative O… Ended

2024-515230-32-00 Inflammatory Conditions 3 2024-10-09
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with … Ended

2023-510472-31-00 Healthy Adult Participants 3 2024-07-05
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole. Ended

2023-510467-35-00 Healthy Adult Participants. 3 2024-06-05
A two-part trial in healthy volunteers to find out how long JNJ-77242113 stays in and acts on the body when administered as different tablet… Ended

2024-512220-11-00 Inflammatory Conditions 3 2024-05-23
A study to assess the effect of single and repeated doses of JNJ-81241459 on a single dose of certain other drugs, when given together to he… Ended

2023-509030-19-00 Plaque Psoriasis 3 2024-03-18
A study to evaluate how the body absorbs, breaks down and removes drug as well as safety and tolerability when two drugs are administered to… Ended

2023-506580-34-00 Healthy Volunteers 3 2024-01-04
A study to investigate JNJ-80202135 (nipocalimab) delivered subcutaneously via prefilled syringe autoinjector and via normal syringe Ended

2023-504280-16-00 Healthy Volunteers 3 2023-10-17
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess Ho… Ended

2023-505684-36-00 Healthy Volunteers 1 2023-10-09
A clinical trial to evaluate the absolute bioavailability and metabolic profile of aticaprant when administered as an oral tablet and a micr… Ended

2022-502969-19-00 Healthy Adult Participants 3 2023-09-27
A study investigating the absorption and food effect of different tablet formulations of JNJ-77242113, a new compound in the treatment of in… Ended

2023-504720-26-00 Inflammatory Conditions 3 2023-07-19
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics)… Ended

2022-502951-77-00 Healthy Adult Participants 3 2023-05-05
A Clinical Study to Assess the Safety, Tolerability of JNJ-63733657 and to evaluate how fast and to what extent JNJ-63733657 reaches the blo… Ended

2024-513656-15-00 Alzheimer's Disease (Healthy Participants) 3 2022-10-17
A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinet… Ended

2023-504055-27-00 Bipolar depression 3